The ADP receptor P2Y1 is necessary for normal thermal sensitivity in cutaneous polymodal nociceptors

Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Molecular Pain (Impact Factor: 3.53). 02/2011; 7:13. DOI: 10.1186/1744-8069-7-13
Source: PubMed

ABSTRACT P2Y1 is a member of the P2Y family of G protein-coupled nucleotide receptors expressed in peripheral sensory neurons. Using ratiometric calcium imaging of isolated dorsal root ganglion neurons, we found that the majority of neurons responding to adenosine diphosphate, the preferred endogenous ligand, bound the lectin IB4 and expressed the ATP-gated ion channel P2X3. These neurons represent the majority of epidermal afferents in hairy skin, and are predominantly C-fiber polymodal nociceptors (CPMs), responding to mechanical stimulation, heat and in some cases cold.
To characterize the function of P2Y1 in cutaneous afferents, intracellular recordings from sensory neuron somata were made using an ex vivo preparation in which the hindlimb skin, saphenous nerve, DRG and spinal cord were dissected in continuum, and cutaneous receptive fields characterized using digitally-controlled mechanical and thermal stimuli in male wild type mice. In P2Y1-/- mice, CPMs showed a striking increase in mean heat threshold and a decrease in mean peak firing rate during a thermal ramp from 31-52°C. A similar change in mean cold threshold was also observed. Interestingly, mechanical testing of CPMs revealed no significant differences between P2Y1-/- and WT mice.
These results strongly suggest that P2Y1 is required for normal thermal signaling in cutaneous sensory afferents. Furthermore, they suggest that nucleotides released from peripheral tissues play a critical role in the transduction of thermal stimuli in some fiber types.


Available from: Sabrina Mcilwrath, Apr 21, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: P2Y receptors are G protein-coupled receptors (GPCRs) that are activated by adenine and uridine nucleotides and nucleotide sugars. There are eight subtypes of P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14), which activate intracellular signaling cascades to regulate a variety of cellular processes, including proliferation, differentiation, phagocytosis, secretion, nociception, cell adhesion, and cell migration. These signaling cascades operate mainly by the sequential activation or deactivation of heterotrimeric and monomeric G proteins, phospholipases, adenylyl and guanylyl cyclases, protein kinases, and phosphodiesterases. In addition, there are numerous ion channels, cell adhesion molecules, and receptor tyrosine kinases that are modulated by P2Y receptors and operate to transmit an extracellular signal to an intracellular response. WIREs Membr Transp Signal 2012, 1:789–803. doi: 10.1002/wmts.62 For further resources related to this article, please visit the WIREs website.
    11/2012; 1(6). DOI:10.1002/wmts.62
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabotropic P2Y receptors subfamily consists of eight functional mammalian receptors. Specifically, P2Y(1), P2Y(6) and P2Y(11) receptors have been described in the sensory nervous system, but their participation, at peripheral level, in behavioral pain models is scarcely understood. This study assessed the role of peripheral P2Y(1), P2Y(6) and P2Y(11) receptors in formalin-induced inflammatory pain. Ipsilateral, but not contralateral peripheral pre-treatment with the endogenous P2Y(1) (ADP, 100-1000 nmol/paw), P2Y(6) (UDP, 180-300 nmol/paw) and P2Y(11) (ATP, 100-1000 nmol/paw), or selective P2Y(1) (MRS2365, 0.1-10 nmol/paw), P2Y(6) (PS130474, 0.1-0.10 pmol/paw) and P2Y(11) (NF546, 0.3-3 nmol/paw) receptor agonists increased 0.5% formalin-induced flinching behavior. Concordantly, peripheral pre-treatment with the selective P2Y(1) (MRS2500, 0.01-10 pmol/paw), P2Y(6) (MRS2578, 3-30 nmol/paw) and P2Y(11) (NF340, 1-10 nmol/paw) receptor antagonists significantly decreased 1% formalin-induced flinching behavior. Furthermore, the pronociceptive effect of ADP (100 nmol/paw) or MRS2365 (10 nmol/paw), UDP (300 nmol/paw) or PSB0474 (10 pmol/paw) and ATP (1000 nmol/paw) or NF546 (3 nmol/paw) was blocked by the selective P2Y(1) (MRS2500, 0.01 nmol/paw), P2Y(6) (MRS2578, 3 nmol/paw), and P2Y(11) (NF340, 1 nmol/paw) receptor antagonists, respectively. Western blot analysis confirmed the presence of P2Y(1) (66 kDa), P2Y(6) (36 kDa) and P2Y(11) (75 kDa) receptors in dorsal root ganglia (DRG) and sciatic nerve. Results suggest that peripheral activation of P2Y(1), P2Y(6) and P2Y(11) receptors plays a pronociceptive role in formalin-induced pain.
    Pharmacology Biochemistry and Behavior 11/2014; 128. DOI:10.1016/j.pbb.2014.11.001 · 2.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ischemic myalgia is a unique type of muscle pain in the patient population. The role that discrete muscle afferent subpopulations play in the generation of pain during ischemic events, however, has yet to be determined. Using two brachial artery occlusion models to compare prolonged ischemia or transient ischemia with reperfusion of the muscles, we found that both injuries caused behavioral decrements in grip strength, as well as increased spontaneous pain behaviors. Using our ex vivo forepaw muscles, median and ulnar nerves, dorsal root ganglion (DRG), and spinal cord recording preparation, we found after both prolonged and transient ischemia, that there was a significant increase in the number of afferents that responded to both noxious and non-noxious(36) chemical (lactate, ATP, varying pH) stimulation of the muscles compared to uninjured controls. However, we found an increase in firing to heat stimuli specifically in muscle afferents during prolonged ischemia, but a distinct increase in afferent firing to non-noxious chemicals and decreased mechanical thresholds after transient ischemia. The unique changes in afferent function observed also corresponded with distinct patterns of gene expression in the DRGs. Thus the development of ischemic myalgia may be generated by unique afferent based mechanisms during prolonged and transient ischemia.
    Journal of Pain 09/2014; 15(12). DOI:10.1016/j.jpain.2014.09.003 · 4.22 Impact Factor